Connect with us

Good News

Winners of Women in Healthcare Awards announced in Edinburgh

Published

on

Winners of Global Women in Healthcare Awards announced in Edinburgh
Prof Angela Thomas and Dr Mumtaz Patel, winner of the Outstanding Leader Award | Photo: EMMS International

Healthcare professionals from several parts of the UK gathered last Saturday, March 9th, for the inaugural Global Women in Healthcare Awards.

The event, launched by Scotland’s healthcare INGO, EMMS International, and the Royal College of Physicians of Edinburgh, celebrated the achievements of women in healthcare. The occasion also highlighted the importance of supporting healthcare academic study across all communities. Attendees heard speeches from Dr Cathy Ratcliff, CEO of EMMS International, Dr Kerri Baker, Dean of Education at the Royal College of Physicians of Edinburgh, and Professor Linda Bauld OBE, the Bruce and John Usher Chair of Public Health in The Usher Institute at the University of Edinburgh and Chief Social Policy Advisor to the Scottish government.

The Global Women in Healthcare Awards were split into four categories. In a nod to Scottish doctor and founder of the Scottish Women’s Hospitals, the Dr. Elsie Inglis Award recognised a woman who championed sex equality in the medical profession. The Rising Star Award celebrated a woman who demonstrated potential and dedication to a career in healthcare. And the Outstanding Leader Award was given to a professional supporting other women in their healthcare careers.

“Women are underrepresented in healthcare leadership. Recognising their contribution and inspiring colleagues to follow in their footsteps is key to building resilient health systems,” said Professor Linda Bauld OBE, who sat on the judging panel for the Outstanding Leader Award.

Winner of the Global Women in Healthcare Awards

The Dr Elsie Inglis Award

Winner: Dr Kate Womersley – Recognised for her work to drive the adoption of a new minimum standard for inclusion of sex and gender in science, changing the face of medical and social research in the UK.

A doctor in Psychiatry, Dr Womersley writes about medicine, gender and women’s health. Her research aims to improve sex and gender equity in biomedical research, funded by the Wellcome Trust.

The Rising Star Award

Winner: Dr Maneh Gizhlaryan – Recognised for her work in paediatric haematology and stem cell transplantation (HSCT) in Armenia, benefiting current patients and inspiring other young women to enter medicine, science and academia.

Dr. Gizhlaryan is a Paediatric Haemato-Oncologist at the Paediatric Cancer and Blood Disorders Centre of Armenia, Yeolyan Haematology and Oncology Centre.

The Outstanding Leader Award,

Winner: Dr Mumtaz Patel – Awarded for her work in undergraduate and postgraduate medical training to support physicians to fulfil their full potential, promoting leadership and the delivery of patient-centered care.

Dr Patel is Consultant Nephrologist at Manchester University Hospitals NHS Foundation Trust; Postgraduate Associate Dean at Health Education England North-West; Director of Conduct and Progress at the School of Medicine, University of Liverpool; and Vice President, Education and Training, at Royal College of Physicians.

The Health Tech Award

Winner: Charlotte Casebourne Stock and Margaret Duffy – Awarded for their work in the oncolytic viral therapy field to benefit cancer patients. Charlotte Casebourne Stock is Co-Founder and CEO, and Margaret Duffy is Co-Founder and CSO at Theolytics, a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.

EuroNewsweek is a dynamic news platform featuring lifestyle, sustainability, successful stories, tech, leadership, creative marketing, business, and the unstoppable people behind them.

Good News

Royal Society honours Northumbria team for reshaping STEM engagement

Published

on

Royal Society honours Northumbria team for reshaping STEM engagement
Mel Horan, Primary Outreach Officer with NUSTEM at Northumbria University.

Northumbria University’s NUSTEM outreach team has been recognised by the Royal Society for work that has quietly reshaped how young people encounter science across the UK. Over the past decade, the group has built long‑term partnerships with schools, families and national organisations, creating evidence‑based resources that help children understand STEM careers and see themselves as potential scientists and engineers. Their approach blends hands‑on engagement with rigorous research — a combination that has now earned them the Royal Society Athena Prize 2026, one of the UK’s most respected honours for advancing diversity in STEM.

A decade of impact across schools and communities

NUSTEM, led by Professor Carol Davenport, has been awarded the Royal Society Athena Prize 2026 for its work promoting equity in STEM and strengthening the research evidence base around effective STEM education and engagement. The prize, awarded every two years, recognises teams that advance diversity in science, technology, engineering and mathematics within their communities.

Since 2014, NUSTEM has partnered with 48 primary schools and 20 secondary schools across the North East, plus a wider network across the UK. The team has recorded more than 150,000 interactions with children and young people, and nearly 33,000 with teachers, parents, carers and the broader STEM community. Their work ranges from family STEM activities to classroom resources that help children develop a ‘science identity’ and understand the breadth of STEM careers.

Setting a national benchmark for inclusive STEM engagement

NUSTEM also supports companies and STEM organisations in developing outreach programmes, including through its attributes‑led approach to career‑related learning — now used by groups such as the British Science Association and the Science and Technology Facilities Council’s Public Engagement teams.

Professor Carol Davenport said: “The NUSTEM team is delighted to have our long-term work to support diversity in STEM recognised by the Royal Society. Our approach has always been to meld high-quality engagement practice with excellent research in the field of STEM engagement.”

The award follows NUSTEM’s 2025 William Thomson, Lord Kelvin Medal and Prize for public engagement in physics. Professor Andy Shepherd, Interim Pro Vice-Chancellor for the Faculty of Science and Environment, said the Royal Society’s recognition “sets a benchmark for the sector.”

Continue Reading

Good News

Great Northern joins Stevenage FC players to support town’s homeless

Published

on

Great Northern joins Stevenage FC players to support town’s homeless
Great Northern staff are collecting anything with a decent shelf life, such as tinned food, coffee and tea. | Photo: Peter Alvey/ GN

To address the cost of living crisis and mark the 13th anniversary of their partnership with Stevenage Football Club Academy, Great Northern’s railway station staff are calling on town commuters to help them support a town-based charity for homeless people.

All week from 8am-11am up to and including this Thursday (27 August) the station staff are collecting food donated by passengers for a homeless drop-in centre for people in need that is run out of Stevenage FC football stadium.

Every Monday, from 5-7pm, charity Feed Up, Warm Up provides a hot meal and a hot drink for up to 120 people in need and others suffering from the cost of living crisis, many of them homeless, from the centre they set up in the Sporta Stadium, Stevenage. The academy players help at the drop-in centre, learning valuable skills.

“For 13 years now, we’ve been supporting 16-18-year-old Stevenage FC Academy players by giving them free train travel to and from their practice games and study. We think it’s a great scheme and one we really want to support.

“This year, to develop that partnership still further, we decided to join the club in supporting this hugely worthwhile charity. There’s a real cost of living crisis going on and anything we and can do with our customers at the station has to be a good thing,” Great Northern’s CSR Manager Tracy Jarvis said.

Not everyone is homeless – many simply struggle to make ends meet which is why Feed Up, Warm Up has a foodbank service as part of the drop-in (as well as offering emergency supplies such as sleeping bags and toiletries and a barbering service).

Continue Reading

Good News

When Will Europe End Animal Testing?

Published

on

When Will Europe End Animal Testing
Nearly 500,000 animal procedures are still carried out each year in the EU for chemical safety compliance. | Photo: Dibbendu Koley.

Europe is aiming to end animal testing in chemical safety assessments. The European Commission’s newly adopted roadmap, published on 1 June 2026, sets out how the EU intends to shift away from long‑established animal experiments and replace them with modern, non‑animal scientific methods. The plan is not a vague political gesture: it is a structured programme covering 15 regulatory areas, from industrial chemicals and pesticides to pharmaceuticals and food additives. It responds directly to public pressure, including more than 1.2 million signatures gathered through the European Citizens’ Initiative “Save Cruelty‑Free Cosmetics”, and acknowledges that nearly 500,000 animal procedures are still carried out each year in the EU solely for chemical safety compliance.

The roadmap marks the first time the EU has committed to a coordinated, cross‑sector strategy to phase out animal testing in this field.

A Three‑Pillar Plan to Replace Animal Tests

The roadmap is built around three pillars designed to accelerate the shift towards non‑animal science while maintaining strict safety standards. The first pillar focuses on “making change happen”, offering more than 30 recommendations to replace, reduce or refine animal tests across human health and environmental assessments. These include expanding access to the Joint Research Centre’s facilities for developing alternatives and creating mechanisms to identify regulatory gaps where non‑animal methods can be introduced.

The second pillar aims to keep Europe at the forefront of scientific innovation. This includes supporting research networks, investing in artificial intelligence and data‑driven toxicology, and encouraging the development of internationally recognised standards for non‑animal approaches. The Commission argues that this shift is not only ethical but economically strategic, strengthening Europe’s competitiveness by adopting cutting‑edge technologies.

The third pillar focuses on collaboration within the EU and globally. Regulators, agencies, researchers and industry will work together to ensure consistent implementation, with progress monitored through indicators built into the roadmap. A high‑level conference in 2029 will assess how widely non‑animal methods have been adopted across EU legislation, including REACH.

Why Europe Is Moving Away from Animal Testing

The shift is driven by a combination of ethics, science and public demand. Across the EU, around 500,000 animal procedures are carried out each year for chemical safety assessments alone. These tests can involve force‑feeding chemicals to animals daily for months, causing pain, organ damage and death. A single reproductive toxicity test can use up to 2,500 animals for just one chemical.

At the same time, scientific alternatives have advanced rapidly. Modern in vitro systems, computational toxicology and AI‑supported modelling can often predict chemical effects more accurately than traditional animal tests. The Commission acknowledges that not all methods are ready to replace every test, but the roadmap is designed to accelerate validation and regulatory acceptance.

When can Europe Realistically End Animal Testing?

While the transition will take time, the EU Commission has already begun implementation. Experts expect the most visible reductions to occur between 2029 and the mid‑2030s, as new methods gain regulatory acceptance and older requirements are rewritten.

Based on the Commission’s timeline and expert analysis, the stages for the long anticipated transition will include:

  • 2026–2030: Early implementation, increased funding, validation of new methods, and initial reductions in animal use.
  • 2030–2035: Wider regulatory acceptance of non‑animal approaches across multiple sectors.
  • Beyond 2035: A realistic window for a near‑complete phase‑out, depending on scientific progress and legislative reform.

The EU Commission has already begun implementing the roadmap, signalling that the political commitment is in place. The 2029 review will be a key moment to assess whether the EU is on track.

Continue Reading

Trending